Creative Biolabs-Immuno-oncology

Anti-FLT3 (clone 24F22) SynExpress C-Cy3-L/T-E CD8+ T Cells (CAT#: ITS-1124-CR221)

DatasheetDatasheet
Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target FLT3 ( clone 24F22). We employs the HBV (CMV-Cy3-LEF/TCF-EcoRI) vector components and the SynExpress system of the introns Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
FLT3
Clone
24F22
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.89
Cell Culture
Adherent Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.